{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-061853","form_type":"8-K","ticker":"SXTP","cik":"0001946563","company_name":"60 DEGREES PHARMACEUTICALS, INC.","filed_at":"2024-07-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:15.251294+00:00","generated_at":"2026-05-31T20:34:50.231846+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"60 Degrees Pharma shareholders approve 1:5-1:12 reverse split and 5M share increase","bullets":["All five director nominees elected; each received >3.6M votes for.","Amendment to 2022 Equity Plan approved: 5M new shares authorized for issuance.","Reverse stock split authorized at ratio between 1:5 to 1:12, effective date to be set by board.","Modification of CEO/CFO option strike price and consultant option issuance both approved to comply with Nasdaq listing rules.","Ratification of RBSM LLP as independent auditor for FY2024 approved with 6.2M votes for."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-061853","json":"https://secwatch.observer/filing/0001213900-24-061853.json","markdown":"https://secwatch.observer/filing/0001213900-24-061853.md","text":"https://secwatch.observer/filing/0001213900-24-061853.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1946563/000121390024061853/0001213900-24-061853-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1946563/000121390024061853/ea0209525-8k_60degrees.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T20:34:50.231846+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}